CTLA 4 News and Research

RSS
New approach to enhance the therapeutic efficacy of liver cancer immunotherapy

New approach to enhance the therapeutic efficacy of liver cancer immunotherapy

Study shows difference in outcomes for women treated with checkpoint inhibitors for melanoma

Study shows difference in outcomes for women treated with checkpoint inhibitors for melanoma

HSS study provides insight into real-world medication use for treatment of psoriatic arthritis

HSS study provides insight into real-world medication use for treatment of psoriatic arthritis

Study opens a window for new therapeutic approaches to ovarian cancer

Study opens a window for new therapeutic approaches to ovarian cancer

UAB researchers show how to identify non-responding tumors and improve immunotherapy response

UAB researchers show how to identify non-responding tumors and improve immunotherapy response

Study findings could lead to novel ways to overcome tumor resistance to immunotherapies

Study findings could lead to novel ways to overcome tumor resistance to immunotherapies

MD Anderson and SNIPR BIOME join forces to advance new CRISPR-based microbiome therapeutics

MD Anderson and SNIPR BIOME join forces to advance new CRISPR-based microbiome therapeutics

'Cold' tumors can be turned 'hot' with extremely low doses of radiation, study shows

'Cold' tumors can be turned 'hot' with extremely low doses of radiation, study shows

Cellular program could turn T cells into effective cancer killers

Cellular program could turn T cells into effective cancer killers

MSK researchers identify potential biomarker of response to checkpoint immunotherapy

MSK researchers identify potential biomarker of response to checkpoint immunotherapy

New prediction model can identify NSCLC patients who are not likely to respond to immunotherapy

New prediction model can identify NSCLC patients who are not likely to respond to immunotherapy

Study finds durable responses to immunotherapy in rare angiosarcomas

Study finds durable responses to immunotherapy in rare angiosarcomas

Two-arm molecule can deplete cancer-protecting cells to promote immune responses against tumors

Two-arm molecule can deplete cancer-protecting cells to promote immune responses against tumors

New dietary fiber formulation improves the potency of cancer immunotherapies

New dietary fiber formulation improves the potency of cancer immunotherapies

Cancer immunotherapy may self-limit its efficacy in fighting tumors, study finds

Cancer immunotherapy may self-limit its efficacy in fighting tumors, study finds

Yale researchers provide new insights into acquired resistance to cancer immunotherapy

Yale researchers provide new insights into acquired resistance to cancer immunotherapy

Study characterizes shifting neoantigen burden between primary and metastatic tumors within HNSCC

Study characterizes shifting neoantigen burden between primary and metastatic tumors within HNSCC

Compound isolated from Moroccan fungus shows promise to fight triple negative breast cancer

Compound isolated from Moroccan fungus shows promise to fight triple negative breast cancer

Sequential administration of immunotherapy and targeted therapy prolongs anti-tumor responses

Sequential administration of immunotherapy and targeted therapy prolongs anti-tumor responses

Study suggests a new way to personalize anti-CTLA-4 therapy for cancers

Study suggests a new way to personalize anti-CTLA-4 therapy for cancers